NICE (NASDAQ:NICE – Get Free Report) had its price objective reduced by equities researchers at Citigroup from $279.00 to $228.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. Citigroup’s price objective indicates a potential upside of 41.43% from the stock’s previous close.
NICE has been the subject of a number of other reports. Piper Sandler restated a “neutral” rating on shares of NICE in a research report on Thursday, November 14th. Royal Bank of Canada lowered their target price on shares of NICE from $260.00 to $200.00 and set an “outperform” rating for the company in a report on Friday. Northland Securities dropped their price target on shares of NICE from $275.00 to $250.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Jefferies Financial Group reissued a “hold” rating and issued a $200.00 price objective (down from $215.00) on shares of NICE in a research report on Thursday, December 19th. Finally, Barclays dropped their target price on NICE from $286.00 to $226.00 and set an “overweight” rating for the company in a research report on Friday. Four investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $231.64.
Check Out Our Latest Stock Report on NICE
NICE Price Performance
NICE (NASDAQ:NICE – Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The technology company reported $2.25 earnings per share for the quarter, missing the consensus estimate of $2.96 by ($0.71). The company had revenue of $721.60 million for the quarter, compared to the consensus estimate of $718.47 million. NICE had a return on equity of 16.17% and a net margin of 16.18%. As a group, sell-side analysts forecast that NICE will post 9.85 EPS for the current fiscal year.
Institutional Trading of NICE
A number of hedge funds have recently bought and sold shares of the stock. McIlrath & Eck LLC boosted its holdings in NICE by 56.9% in the fourth quarter. McIlrath & Eck LLC now owns 160 shares of the technology company’s stock worth $27,000 after acquiring an additional 58 shares in the last quarter. Financial Perspectives Inc raised its position in shares of NICE by 11.6% in the 4th quarter. Financial Perspectives Inc now owns 635 shares of the technology company’s stock valued at $108,000 after purchasing an additional 66 shares during the last quarter. Richardson Financial Services Inc. boosted its stake in NICE by 43.8% in the 4th quarter. Richardson Financial Services Inc. now owns 220 shares of the technology company’s stock worth $38,000 after purchasing an additional 67 shares in the last quarter. Dorsey & Whitney Trust CO LLC boosted its stake in NICE by 5.7% in the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 1,428 shares of the technology company’s stock worth $243,000 after purchasing an additional 77 shares in the last quarter. Finally, Berry Wealth Group LP grew its position in NICE by 5.2% during the 4th quarter. Berry Wealth Group LP now owns 1,616 shares of the technology company’s stock worth $274,000 after purchasing an additional 80 shares during the last quarter. Hedge funds and other institutional investors own 63.34% of the company’s stock.
NICE Company Profile
NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing.
Read More
- Five stocks we like better than NICE
- How to Short a Stock in 5 Easy StepsĀ
- 3 Beaten Down Healthcare Stocks Recovering in 2025
- How to Invest in Blue Chip Stocks
- These 3 Unusual ETFs Have Dominated the S&P 500’s Performance YTD
- Dividend Capture Strategy: What You Need to Know
- UnitedHealth’s RSI Suggests It Is Extremely Oversold
Receive News & Ratings for NICE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NICE and related companies with MarketBeat.com's FREE daily email newsletter.